Efficacy and safety of edaravone sublingual tablet on cognitive impairment in patients with cerebral small vessel disease: A randomized, double-blind, placebo-controlled, multicenter trial

The requested reference [a69904ae726f6819ffe0d5cee51ce5e92e4068de] no longer exists in our database. It has been replaced by the current reference: [61d3bcdd476f4b8bb71ca9c21738b0f937975245]

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2024
This article has no abstract
Epistemonikos ID: 8bbb355184b2375219e7df9eff154b7e2b0c5024
First added on: Apr 08, 2025